首页 › 基金 › NEXTBio Capital Management LP › VNDA

NEXTBio Capital Management LP 对 VNDA 的持仓历史

VANDA PHARMACEUTICALS INC · 医疗保健

NEXTBio Capital Management LP 在 Q3 2026 的 13F 申报中披露持有 VNDA(VANDA PHARMACEUTICALS INC)100,000 股,市值约 US$2.0M,约占其申报组合的 0.87%,在其申报持仓中市值排名第 22 位。 NEXTBio Capital Management LP 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)100.00K 股
申报持仓市值$1.99M
组合权重0.87%
首次申报Q3 2026
最近变动新进
更新于2026-11-13

最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR

NEXTBio Capital Management LP 对 VNDA 的持仓演变

NEXTBio Capital Management LP 于 Q3 2026 首次披露 VNDA 持仓:100,000 股(约 US$2.0M)。

逐季持仓明细

季度股数金额变化
Q3 2026 100.00K $1.99M 新进

关于 VNDA 与 13F 数据

VNDA(VANDA PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 33 只申报持有 VNDA,申报仓位最大的包括:Siren, L.L.C. (US$38.4M), AIGH Capital Management LLC (US$11.0M), Krensavage Asset Management, LLC (US$7.2M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 VNDA 的基金

查看 VNDA 的全部基金持有人 →

常见问题

How long has NEXTBio Capital Management LP held VNDA?

NEXTBio Capital Management LP has disclosed VNDA holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is NEXTBio Capital Management LP's current position in VNDA?

As of Q3 2026, NEXTBio Capital Management LP holds 100.00K shares of VNDA (VANDA PHARMACEUTICALS INC), valued at $1.99M, representing 0.87% of its reported portfolio and ranking #22.

Has NEXTBio Capital Management LP been buying or selling VNDA?

In the latest 13F filing (Q3 2026), NEXTBio Capital Management LP newly opened its position in VNDA.

Which other funds hold VNDA?

Other major institutional holders of VNDA include Siren, L.L.C., AIGH Capital Management LLC, Krensavage Asset Management, LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.